We present an update of our experience with the ketogenic diet (KD) in @entity1 with @entity3148 ( @entity3148 ) to evaluate the efficacy and tolerability and our short experience with vagus nerve stimulation (VNS) in the treatment of this syndrome. Between @entity3490 , 1990 and May 31, 2007, 59 @entity1 who met diagnostic criteria for @entity3148 were studied in our department. Twenty-four of them were placed on the KD and were followed up for a minimum of 2 years. Three @entity1 were treated with VNS. Sixteen (66.6%) of 24 @entity1 remained on the diet. Two @entity1 (12.5%) became @entity410 free, 10 @entity1 (62.5%) had a 75-99% decrease in @entity410 , and the remaining 4 @entity1 (25%) had a 50-74% decrease in @entity410 . Six @entity1 have been off the diet for >2 years; one of them is @entity410 free, two have @entity410 , and three, who abandoned the diet after 3 years of adhering to it, relapsed. As to the efficacy of VNS, two @entity1 had a 50-74% decrease in @entity410 and in the other @entity410 frequency remained unchanged. The device was well tolerated in all @entity1 without significant complications. Considering the severity and refractarity of @entity410 in @entity1 with @entity3148 , the fact that 12 of 16 @entity1 who remained on the diet had a significant reduction in number of @entity410 shows that the KD is at present an interesting therapeutic option. VNS may be a good alternative treatment for @entity3148 .

Nonpharmacologic treatments of XXXX : focus on the ketogenic diet.

@entity1 :: ('9606', 'Species') :: ['children', 'patients'] @entity410 :: ('MESH:D012640', 'Disease') :: ['seizure', 'seizures', 'sporadic seizures'] @entity3490 :: ('55016', 'Gene') :: ['March 1'] @entity3148 :: ('MESH:D004831', 'Disease') :: ['Dravet syndrome', 'DS']
@entity3148 :: (MESH:D004831,Disease) :: ['Dravet syndrome']
